Alkermes News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

18.04.17	Research Reports Initiation on Healthcare Stocks -- Valeant Pharma, Delcath Systems, Alkermes, and Amphastar Pharma (PR Newswire)
24.02.17	Healthcare Stocks on Investors' Radar -- Alkermes, Teleflex, Cascadian Therapeutics, and InspireMD (PR Newswire)
15.02.17	EARNINGS SUMMARY: Details of Alkermes plc Q4 Earnings Report (RTTNews)
13.01.17	Healthcare Stocks Under Scanner -- Valeant Pharma, Alkermes, Universal Health Services, and LifePoint Health (PR Newswire)
02.11.16	EARNINGS SUMMARY: Details of Alkermes plc Q3 Earnings Report (RTTNews)
08.08.16	Alkermes Submits SNDA For Dosing Option Of ARISTADA To Treat Schizophrenia (RTTNews)
28.07.16	EARNINGS SUMMARY: Details of Alkermes plc Q2 Earnings Report (RTTNews)
28.04.16	Alkermes Plans To Initiate Second Trial Of ALKS 7119 (RTTNews)
28.04.16	EARNINGS SUMMARY: Details of Alkermes plc Q1 Earnings Report (RTTNews)
31.03.16	Alkermes : Study On Naltrexone In Opioid-Dependent Patients Published (RTTNews)
25.02.16	Alkermes Announces Its Financial Expectations For 2016 - Quick Facts (RTTNews)
25.02.16	EARNINGS SUMMARY: Details of Alkermes plc Q4 Earnings Report (RTTNews)
10.02.16	Alkermes Starts Phase 3 Study Of ALKS 3831 To Evaluate Weight Gain (RTTNews)
22.01.16	AMGN Gets FDA Nod, Data Awaits RGLS In Feb, FORWARD Puts ALKS On The Back Foot (RTTNews)
21.01.16	Alkermes: Two Phase 3 Studies Of ALKS 5461 Fails To Meet Primary Endpoint (RTTNews)
29.10.15	Alkermes Announces Streamlined Registration Pathway For ALKS 8700 (RTTNews)
29.10.15	EARNINGS SUMMARY: Details of Alkermes plc Q3 Earnings Report (RTTNews)
06.10.15	CTRV Grabs Headlines, Watch Out For EXAS Today, ONCE Gets A Spark (RTTNews)
06.10.15	Alkermes: FDA Approves ARISTADA For Treatment Of Schizophrenia (RTTNews)
30.07.15	EARNINGS SUMMARY: Details of Alkermes plc Q2 Earnings Report (RTTNews)
30.04.15	Alkermes Q1 Loss Widens (RTTNews)
06.04.15	Alkermes Study Shows ALKS 3831's Favorable Efficacy And Mean Weight Gain Profile (RTTNews)
09.03.15	Alkermes Announces Sale Of Gainesville To Recro Pharma, Inc. - Quick Facts (RTTNews)
24.02.15	Alkermes Q4 Profit Surges - Quick Facts (RTTNews)
24.02.15	Alkermes Says Not To Pursue Further Development Of ALKS 7106 - Quick Facts (RTTNews)
23.02.15	Alkermes Names Mark Namchuk SVP Research, Pharma And Nonclinical Development (RTTNews)
09.02.15	Alkermes Reports Positive Topline Results From Phase 1 Study Of ALKS 8700 In MS (RTTNews)
07.01.15	ALKS Moves Forward, KBIO Craters, GILD Opens Wallet, TRVN For The Long Haul (RTTNews)
06.01.15	Alkermes Posts Positive Study Results Of ALKS 5461 For Major Depressive Disorder (RTTNews)
29.10.14	Alkermes Q3 Adj. Profit Tops View - Quick Facts (RTTNews)
26.08.14	ADXS Makes It Big, ALKS Waiting To Face FDA, ITMN Snapped Up, KITE Flies High (RTTNews)
25.08.14	Alkermes Submits NDA To FDA For Schizophrenia Treatment Aripiprazole Lauroxil (RTTNews)
31.07.14	Alkermes Reports Q2 Non-GAAP EPS Of $0.11; Updates FY14 Guidance (RTTNews)
17.07.14	Alkermes Begins Phase 1 Study Of ALKS 8700 For Treatment Of Multiple Sclerosis (RTTNews)
09.04.14	ALKS, SGEN To Watch Out, Capstone Dons New Hat, PRTA Pockets $15 Mln (RTTNews)
08.04.14	Alkermes: Schizophrenia Experimental Drug Meets Primary Goal In Phase 3 Trial (RTTNews)
08.04.14	Alkermes Reports Positive Results From Phase 3 Study Of Aripiprazole Lauroxil (RTTNews)
27.02.14	Alkermes Q3 Profit Rises; Issues Calendar-Year 2014 Guidance - Quick Facts (RTTNews)
08.01.14	Alkermes Reports New Developments On Late-stage Central Nervous System Pipeline (RTTNews)
31.10.13	Alkermes Plc Q2 Loss Narrows - Quick Facts (RTTNews)
10.10.13	Alkermes' ALKS 5461 For Major Depressive Disorder Gets Fast Track Status By FDA (RTTNews)
10.10.13	ARIA Loses Pace, DVAX On The Move, BDSI, CHTP Get FDA Dates, ACUR Buys Peace (RTTNews)
04.10.13	Events, Appointments, Approvals, Recommendations, and Agreements - Research Report on Elan, Alkermes, Hospira, pSivida, and Kindred (PR Newswire)
01.10.13	Technical Briefing: Celsion Corp., Theravance Inc., Alkermes PLC, and Hospira Inc. (PR Newswire)
27.08.13	Today's Technical View: Alkermes plc, Hospira Inc., Celsion Corp., and Theravance Inc. (PR Newswire)
22.07.13	Technical Study: Hospira, Alkermes, Theravance, and Celsion (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

UBS Group	27.65	2.14 %	K V
Novartis	88.82	1.30 %	K V
Part Grp Hldg	1’233.00	1.23 %	K V
Kuehne+Nagel Int	207.50	1.22 %	K V
Lonza Grp	538.00	1.05 %	K V
Swisscom	503.00	0.40 %	K V
Sonova Hldg	296.60	0.34 %	K V
Swiss Life Hldg	697.40	0.11 %	K V
Zurich Insur Gr	539.60	0.11 %	K V
Holcim	87.40	0.02 %	K V

Nachrichten zu Alkermes PLC

Aktien Top/Flop

Meistgelesene Nachrichten